These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2424755)

  • 1. Concentrations of ciprofloxacin in serum and prostatic tissue in patients undergoing transurethral resection.
    Grabe M; Forsgren A; Björk T
    Eur J Clin Microbiol; 1986 Apr; 5(2):211-2. PubMed ID: 2424755
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial prophylaxis in transurethral surgery.
    Madsen PO; Graversen PH
    Infection; 1986; 14(5):201-2. PubMed ID: 3539810
    [No Abstract]   [Full Text] [Related]  

  • 3. Intraprostatic concentrations of ciprofloxacin after intravenous administration.
    Boerema JB; Debruyne FM; Dalhoff A
    Lancet; 1984 Sep; 2(8404):695-6. PubMed ID: 6147717
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate.
    Wagenlehner FM; Lunz JC; Kees F; Wieland W; Naber KG
    J Chemother; 2006 Oct; 18(5):485-9. PubMed ID: 17127224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin concentrations in tonsils following a single intravenous infusion.
    Falser N; Dalhoff A; Weuta H
    Infection; 1984; 12(5):355-7. PubMed ID: 6511090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of ciprofloxacine antibiotic prophylaxis of infectious complications after TUR of the prostate].
    Rafal'skiĭ VV; Strachunskiĭ LS; Kogan MI; Petrov SB; Grinev AV; Veliev EI; Kopylov VV; Iskorostinskiĭ EV; Kirekhin IV
    Urologiia; 2005; (5):21-5. PubMed ID: 16281834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of an antimicrobial agent to prevent complications following transurethral resection of the prostate. Furadantin.
    Gross M
    Int Surg; 1969 Jun; 51(6):475-8. PubMed ID: 4182528
    [No Abstract]   [Full Text] [Related]  

  • 8. Intraperitoneal penetration of ciprofloxacin.
    Lockley MR; Waldron R; Wise R; Donovan IA
    Eur J Clin Microbiol; 1986 Apr; 5(2):209-10. PubMed ID: 2941284
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of ofloxacin and norfloxacin concentration in prostatic tissues in patients undergoing transurethral resection of the prostate.
    Chen J; Chen RR; Huang HS
    J Formos Med Assoc; 2001 Aug; 100(8):548-52. PubMed ID: 11678006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefotaxime for prevention of infectious complications in bacteriuric men undergoing transurethral prostatic resection. A controlled comparison with methenamine.
    Olsen JH; Friis-Møller A; Jensen SK; Korner B; Hvidt V
    Scand J Urol Nephrol; 1983; 17(3):299-301. PubMed ID: 6196841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of lomefloxacin into human prostatic tissue.
    Leroy A; Humbert G; Fillastre JP; Grise P
    Am J Med; 1992 Apr; 92(4A):12S-14S. PubMed ID: 1374582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibiotics in transurethral resection of the prostate in patients with low risk of infectious complications: randomized prospective comparative study].
    Valdevenito Sepúlveda JP
    Arch Esp Urol; 2004; 57(1):48-57. PubMed ID: 15112871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intravenous ciprofloxacin and mezlocillin in treatment of complicated urinary tract infection.
    Peters HJ
    Eur J Clin Microbiol; 1986 Apr; 5(2):253-5. PubMed ID: 2941295
    [No Abstract]   [Full Text] [Related]  

  • 14. Tissue distribution of ciprofloxacin following oral and intravenous administration.
    Dalhoff A; Eickenberg HU
    Infection; 1985; 13(2):78-81. PubMed ID: 3158611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internal urethrotomy of the prostatic urethra or transurethral resection in benign prostatic hyperplasia.
    D'Ancona CA; Netto NR Júnior ; Cará AM; Ikari O
    J Urol; 1990 Oct; 144(4):918-20. PubMed ID: 1697916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose- and sex-independent disposition of ciprofloxacin.
    Höffler D; Dalhoff A; Gau W; Beermann D; Michl A
    Eur J Clin Microbiol; 1984 Aug; 3(4):363-6. PubMed ID: 6489328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of ciprofloxacin in patients undergoing transurethral prostatic surgery.
    Hellsten S; Forsgren A; Björk T; Grabe M
    Scand J Infect Dis Suppl; 1989; 60():104-7. PubMed ID: 2756349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral fleroxacin prophylaxis in transurethral surgery.
    Gasser TC; Wisard M; Frei R
    J Urol; 1996 Jul; 156(1):146-8. PubMed ID: 8648777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the postoperative use of continuous bladder irrigation in transurethral surgery].
    Carballido Rodríguez JA; Menéndez Ondina L; Gallo Rolania FJ; Olivier Gómez C; del Valle Schaan I
    Actas Urol Esp; 1981; 5(2):89-92. PubMed ID: 6168184
    [No Abstract]   [Full Text] [Related]  

  • 20. [Discontinued oral ciprofloxacin for transurethral resection of the prostate in patients with sterile urine without preoperative bladder catheter].
    Valdevenito Sepúlveda JP; Hernández E
    Arch Esp Urol; 2007 Dec; 60(10):1.189-1.196. PubMed ID: 18273976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.